StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Voting cards

<< Previous

Bullboard Posts

Next >>

Comment by brad129on May 08, 2023 10:32pm

132 Views

Post# 35437741

RE:Voting cards

Anyone voting to allow this? Since right before financials came out we were at 101 million diluted now at 105 million, drip, drip, drip. Next comes small reverse split, then larger reverse as has happened in the not so distant past, James likes to keep the low float to attract better financing. But we all get diluted to non existent holders.

<< Previous

Bullboard Posts

Next >>

The top TSX healthcare stocks under $1